Review Article
Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
Table 1
Marketed nanosystems for cancer treatment.
| Product name | Drug | Type of nanocarrier | Company |
| Daunoxome | Daunorubicin citrate | Liposome | Gilead Science, Cambridge, UK | Doxil | Doxorubicin HCl | Liposome | Johnson and Johnson, NJ, USA | Myocet | Doxorubicin | Liposome | Sopherion Therapeutics, NJ, USA | Caelyx | Doxorubicin HCl | Pegylated liposome | Johnson and Johnson, NJ, USA | Transdrug | Doxorubicin | Poly(alkylcyanoacrylate) nanoparticles | BioAlliance, Paris, France | Genexol-PM | Paclitaxel | Methoxy-PEG-polylactide nanoparticles | Samyang, South Korea | Oncaspar | Pegaspargase | PEG-asparaginase nanoparticles | Enzon, NJ, USA | Abraxane | Paclitaxel | Albumin-bound nanoparticles | American Bioscience, CA, USA |
|
|